Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.

J Hematol Oncol · 2010 · PMC2876054 · PMID 20433767

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The combination of vandetanib and pemetrexed did show a positive trend in the prolongation of PFS compared to pemetrexed alone (17.6 vs. 11.9 weeks).

also in 11,005 other papers

did not reach statistical significanceno p-value reported

The findings from ZEAL were in agreement with ZODIAC results although the primary endpoint did not reach statistical significance in the ZEAL study.

also in 111,027 other papers

a strong trendno p-value reported

These results did not quite achieve statistical significance due to early closure, but the study showed a strong trend toward improved progression-free survival (PFS) and OS [ 7 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.